Chief Innovation Officer
Sama Therapeutics
Russell Hanson is a scientist and executive at the intersection of AI, healthcare, and biotechnology.
As Chief Innovation Officer at Sama Therapeutics, he leads iMAGiNE, a GenAI platform for neuropsychiatry that supports drug discovery, diagnostics, and clinical decision-making. He has co-founded multiple AI and biotech companies, overseen successful exits, and advised on $100M+ transactions.
Russell’s work spans AI drug discovery, neurodegenerative diseases, biosensors, and more, with publications in top scientific journals. A frequent keynote speaker, his mission is to harness AI, chemistry, and synthetic biology to drive global health innovation and improve patient outcomes through data-driven, validated technologies.